Abstract: This brain function measurement device (100) includes a brain blood flow information acquisition unit (1) that acquires brain blood flow information (d1) of a subject (P), a brain function information acquisition unit (30) that acquires brain function correlation information (d3) indicating a relative change in a correlation between respective portions of the brain acquired on the basis of the brain blood flow information measured in a plurality of portions of a brain before and after a task is presented, and a brain function image generation unit (7) that generates a first brain function image (20) in which a relative position of each measurement position (23) for the brain blood flow information and the measurement position at which the correlation acquired on the basis of the brain function correlation information has changed are visually recognizable.

Abstract: A brain function measurement device (100) includes a brain blood flow information acquirer (1) configured to acquire brain blood flow information (d1) of a subject (P), a rest information acquirer (2) configured to acquire rest information (d5) to determine whether or not the subject is at rest, and a controller (3) configured to acquire, as resting measurement data (d2), the brain blood flow information with the rest information satisfying a predetermined condition based on the rest information acquired by the rest information acquirer.

Abstract: This optical measurement system 100 is provided with a plurality of optical measurement units 1 and a control device 2 that controls the optical measurement unit. The control device includes a communication unit 24 that obtains specific state information 30 on whether or not the optical measurement unit is in a measurable state by communication for each of a plurality of optical measurement units, a display unit 25 that collectively displays the obtained state information for each of the plurality of optical measurement units, and a control unit 21 that controls a plurality of optical measurement units so that a simultaneous measurement is performed.

Abstract: The present invention relates to a medicament for preventing or treating an ocular disease comprising cyclo-trans-4-L-hydroxyprolyl-L-serine as an active ingredient, a medicament for preventing or treating dry eye comprising the compound as an active ingredient, and, in particular, a medicament for preventing or treating dry eye having an action of enhancing mucin secretion and an action of enhancing repair of ocular tissue damage caused by dry eye.

Abstract: The optical biometric device according to the invention is provided with: a measurement data display control unit for displaying a number of pieces of measurement data on the three-dimensional head surface image or three-dimensional brain surface image displayed on the display unit, and is formed of: a storage unit for storing channel information that indicates combinations of light sending probes and light receiving probes for acquiring information about the amounts of the received light in measurement portions; and a channel information display control unit for displaying a number of light sending probe points at which light sending probes have been placed and a number of light receiving probe points at which a number of light receiving probes have been placed according to the three-dimensional coordinates displayed on the display unit, and at the same time, for displaying line segments that indicate combinations of light sending probes and light receiving probes for connecting light sending probe points an

Abstract: The present invention relates to a medicament for preventing or treating an ocular disease comprising cyclo-trans-4-L-hydroxyprolyl-L-serine as an active ingredient, a medicament for preventing or treating dry eye comprising the compound as an active ingredient, and, in particular, a medicament for preventing or treating dry eye having an action of enhancing mucin secretion and an action of enhancing repair of ocular tissue damage caused by dry eye.

Abstract: A novel plaster structural assembly is provided for iontophoresis wherein th e assembly is comprised of an electrode layer and a medicament-containing layer in which a water supplying layer is disposed between the electrode layer and the medicament-containing layer with a sealing cover disposed on the outside of the electrode layer. A method for using the structural assembly for iontophoresis is also provided.